‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the brains of people living with Alzheimer’s, preventing it from clumping together,” said Richard Oakley, associate director of research and innovation at the Alzheimer’s Society UK, which funded the research.
Alzheimer's 'First' Achieved With Drug That Hits Hotspots
Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the development of a new compound that they say is a "promising" candidate in the search for new therapies for neurodegenerative diseases,
Promising ‘first’ in Alzheimer’s drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s Disease. For the first time, scientists have developed a drug that works on both major aggregation-promoting ‘hotspots’ of the Tau protein in the brain - a key driver of neurodegeneration.
New Alzheimer’s Drug, RI-AG03, Shows Promise in Preliminary Trials
A team of researchers has reported a significant advance in Alzheimer’s treatment. Their candidate drug, RI-AG03, attacks the accumulation of tau proteins—crucial to the disease’s progression—in lab and animal tests.
Researchers make breakthrough in Alzheimer's disease drug development
An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on both major aggregation-promoting 'hotspots' of the Tau protein in
Researchers say new drug could stop Alzheimer's in its tracks
Researchers have hailed a promising breakthrough in the development of drugs to treat Alzheimer’s disease. For the first time, scientists have created a drug that works by targeting both key areas of a protein linked to the disease.
Neuroscience News1d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
BioWorld1d
RI-AG03 targets main promoters of tau protein aggregation at once
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
technologynetworks1d
New Alzheimer's Treatment Shows Promise by Dual-Targeting Tau Protein
AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...
EurekAlert!2d
Imaging (IMAGE)
Scientists used a special imaging technique to observe how Tau protein clumps in the brain tissue of genetically modified ...
Alzheimer's breakthrough as scientists discover drug that blasts memory robbing hotspots
In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...
EuropaWire1d
Tag Archives: RI-AG03
(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and ...